论文信息 - Characterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma. - 字舞流文

Characterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.

J. Bruin | M. Shahid | G. Dent | C. Nicholson | I. Spiers | J. Zaagsma | R. V. van Amsterdam | J. Boer | E. Barron | J. de Boer | R. Amsterdam | J. Kelly | R. van Amsterdam